AcelRx Pharmaceuticals(ACRX) - 2019 Q3 - Quarterly Report
AcelRx Pharmaceuticals(ACRX)2019-11-07 06:57
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of Each Class: Trading symbol(s) Name of Each Exchange on Which registered: Common Stock, $0.001 par value ACRX The Nasdaq Global Market FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORTS PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Nu ...